Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Rheumatology and Therapy|January 13, 2024
Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five CountriesAlain Saraux, Licia Maria Henrique da Mota, Sanjay Dixit, et al.Current Medical Research and Opinion|January 6, 2006
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registryArthur L Weaver, Richard L Lautzenheiser, Michael H Schiff, et al.BMC Musculoskeletal Disorders|March 16, 2017
Sex differences in gout characteristics: tailoring care for women and menLeslie R Harrold, Carol J Etzel, Allan Gibofsky, et al.Seminars in Arthritis and Rheumatism|June 5, 2013
Proceedings of the 2013 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, et al.Postgraduate Medicine|April 28, 2015
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety studyRoy D Altman, Vibeke Strand, Marc C Hochberg, et al.BMC Musculoskeletal Disorders|November 23, 2014
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology networkLeslie R Harrold, George W Reed, J Timothy Harrington, et al.RMD Open|October 4, 2020
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide surveyBella Mehta, Deanna Jannat-Khah, Mark Alan Fontana, et al.The Journal of Rheumatology|June 3, 2019
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid ArthritisPaul Emery, Bonnie Vlahos, Piotr Szczypa, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2020
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized TrialYusuf Yazici, Timothy E McAlindon, Allan Gibofsky, et al.Health and Quality of Life Outcomes|November 11, 2018
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveysAllan Gibofsky, James Galloway, Joern Kekow, et al.Pageof 6